How Often Do Kids Experience Methotrexate Side Effects?
Methotrexate, used in children for juvenile idiopathic arthritis (JIA), cancer, and psoriasis, causes side effects in 10-30% of pediatric patients overall, varying by dose, route (oral vs. subcutaneous), and condition treated. Low weekly doses for JIA (typically 10-15 mg/m²) lead to milder, manageable effects in most cases, with gastrointestinal issues most frequent.[1][2]
Most Common Side Effects and Their Rates
Nausea and vomiting affect 20-40% of children on methotrexate, often within hours of dosing and decreasing over time or with anti-nausea meds like ondansetron.[2][3]
Stomach pain or upset occurs in 15-25%.[1]
Fatigue hits 10-20%, usually mild.[2]
Mouth sores (stomatitis) appear in 5-15%, more with higher doses.[3]
These resolve quickly after doses and affect fewer kids long-term with folate supplementation, standard in pediatrics.[1]
Serious Side Effects: How Rare Are They?
Severe effects like liver toxicity occur in under 5% with monitoring; elevated enzymes prompt dose adjustments in 10-15% but rarely lead to stopping treatment.[2][4]
Bone marrow suppression (low blood counts) affects 2-5%, mostly reversible.[1]
Infections rise slightly (5-10% higher risk), but pneumonitis is rare (<1%).[3]
High-dose use in cancer causes more issues (up to 50% mucositis), but rescue with leucovorin keeps rates low.[4]
Factors Influencing Side Effects in Kids
Subcutaneous dosing cuts GI effects by 50% compared to oral, with 70-80% of JIA kids tolerating it better.[2]
Folic acid (1 mg daily) reduces nausea by 30-50% and mouth sores by 40%.[1][3]
Younger kids (<6 years) report 10-15% higher GI complaints; genetics and obesity also play roles.[2]
Long-term: 5-10% discontinue due to intolerance after 1-2 years.[4]
Monitoring and Reducing Risks
Pediatric guidelines recommend blood tests every 1-3 months for liver/kidney function, catching 90% of issues early.[1][3]
Baseline checks and vaccinations lower infection risks. Stopping rates drop to <5% with proper management.[2]
[1]: American College of Rheumatology - Methotrexate for JIA
[2]: Pediatric Rheumatology Journal - Methotrexate tolerability in JIA (2018 meta-analysis)
[3]: Cochrane Review - Folate supplementation with methotrexate in children (2020)
[4]: Journal of Clinical Oncology - Pediatric high-dose methotrexate safety (2021)